Cited by 150Treatment of Major DepressionMental Health Treatment and AccessPharmacovigilance and Adverse Drug Reactions

The DOI matches its Crossref record; 140 of the 141 references it cites were found in a registry or an index.

Comparative Risk for Harms of Second-Generation Antidepressants: A Systematic Review and Meta-Analysis

Gartlehner, Gerald, Thieda, Patricia, Hansen, Richard A, Gaynes, Bradley N, DeVeaugh-Geiss, Angela, Krebs, Erin E, Lohr, Kathleen N·2008·Drug Safety

DOI 10.2165/00002018-200831100-00004

Open this paper in CoChat — free account

Abstract

Background Evidence indicates that only minor differences in efficacy exist among second-generation antidepressants for the treatment of major depressive disorder (MDD). However, a comprehensive assessment of both benefits and harms is crucial to evaluate the net benefit.Objective To review systematically the comparative harms of second-generation antidepressants for the treatment of MDD in adults by including both experimental and observational evidence.Data sources We searched MEDLINE, EMBASE, PsychLit, The Cochrane Library and the International Pharmaceutical Abstracts from 1980 to April 2007. We manually searched reference lists of pertinent review articles and explored the Center for Drug Evaluation and Research database to identify unpublished research.Study selection Eligible study designs were trials and observational studies comparing one drug of interest with another.Data extraction Two persons independently reviewed abstracts and full-text articles. One investigator extracted relevant data. A senior reviewer checked data for completeness and accuracy.Data synthesis We included 104 experimental and observational studies. If data were sufficient, we conducted meta-analyses of randomized controlled trials on the relative risk of specific adverse events. Findings indicate that the spectrum of adverse events is similar. The frequency of specific adverse events, however, differed across drugs. Venlafaxine was associated with a significantly higher rate of nausea and vomiting than selective serotonin reuptake inhibitors. Compared with other drugs, paroxetine frequently led to more sexual adverse effects and bupropion to fewer such effects; mirtazapine and paroxetine was associated with more weight gain and sertraline with a higher rate of diarrhoea. Overall, however, these differences did not lead to different discontinuation rates. The evidence is insufficient to draw conclusions about rare but severe adverse events.Conclusions Adverse event profiles are similar among second-generation antidepressants. However, different frequencies of specific adverse events might be clinically relevant and influence the choice of a treatment.

Integrity signals

Registry

Crossref · 10.2165/00002018-200831100-00004

Cites

140 of 140 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,796
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907
Current methods of the U.S. Preventive Services Task Force
Harris, R., Helfand, M., Woolf, S. H., Lohr, K. N., Mulrow, C. D., Teutsch, S. M., & Atkins, D. C. (2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(01)00261-6 · Cited by 1,720
Self-citation
Systematic Reviews in Health Care: Meta‐Analysis in Context
(2001) · doi:10.1002/9780470693926 · Cited by 1,693
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
Ioannidis, J. P. A., Evans, S. J. W., Gøtzsche, P. C., O'Neill, R. T., Altman, D. G., Schulz, K., Moher, D., & for the CONSORT Group* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00009 · Cited by 1,593
Network meta‐analysis for indirect treatment comparisons
Lumley, T. (2002) · Statistics in Medicine · doi:10.1002/sim.1201 · Cited by 1,206
Antidepressants and the Risk of Suicidal Behaviors
Jick, H. (2004) · JAMA · doi:10.1001/jama.292.3.338 · Cited by 587
Prevalence of Sexual Dysfunction Among Newer Antidepressants
Clayton, A. H., Pradko, J. F., Croft, H. A., Montano, C. B., Leadbetter, R. A., Bolden-Watson, C., Bass, K. I., Donahue, R. M. J., Jamerson, B. D., & Metz, A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0414 · Cited by 542
Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.
Montejo, A. L., Llorca, G., Izquierdo, J. A., & Rico‐Villademoros, F. (2001) · PubMed · Cited by 460

Show all 141 references

Research works printed but not linked: 16

Gartlehner, 2006, J Clin Epidemiol, 60, 753
Feighner, 1991, J Clin Psychiatry, 52, 329
Tylee, 1997, Primary Care Psychiatry, 3, 51
Alves, 1999, Primary Care Psychiatry, 5, 57
Bennie, 1995, J Clin Psychiatry, 56, 229
Beasley Jr, 1991, J Clin Psychiatry, 52, 294
Cunningham, 1994, JClin Psychopharmacol, 14, 99
Perry, 1989, J Clin Psychiatry, 50, 290
Lepola, 2003, Int Clin Psychopharmacol, 18, 211, 10.1097/00004850-200307000-00003 · DOI · Paper page
Patris, 1996, Int Clin Psychopharmacol, 11, 129
Kasper, 2005, Am J Geriatr Psychiatry, 13, 884, 10.1097/00019442-200510000-00008 · DOI
Gagiano, 1993, Br J Clin Res, 4, 145
Johnston, 1991, J Clin Psychiatry, 52, 450
Mackay, 1999, Br J Gen Pract, 49, 892
Mackay, 1999, Br J Gen Pract, 49, 871
Liu, 1996, CMAJ, 155, 519

Sorted by citations

A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“It is important to note that there is considerable variability among antidepressants in the nature and severity of side-effects, and these also vary from one individual to another (Gartlehner et al., 2008, 2011).”
Background
Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management
Graff, L. A., Walker, J. R., & Bernstein, C. N. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20873 · Cited by 586
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults
Kennedy, S. H., Lam, R. W. M., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.043 · Cited by 529
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.
Lam, R. W., Kennedy, S. H., Grigoriadis, S., McIntyre, R. S., Milev, R., Ramasubbu, R., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.041 · Cited by 431
Linking neurodevelopmental and synaptic theories of mental illness through DISC1
Brandon, N. J., & Sawa, A. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn3120 · Cited by 431
Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review
Wang, S.-M., Han, C., Bahk, W.-M., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018) · Chonnam Medical Journal · doi:10.4068/cmj.2018.54.2.101 · Cited by 299
Side effects of antidepressants during long-term use in a naturalistic setting
Bet, P. M., Hugtenburg, J. G., Penninx, B. W. J. H., & Hoogendijk, W. J. G. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.05.001 · Cited by 239
Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials: A Systematic Review and Meta-Analysis
Rief, W., Nestoriuc, Y., von Lilienfeld-Toal, A., Dogan, I., Schreiber, F., Hofmann, S. G., Barsky, A. J., & Avorn, J. (2009) · Drug Safety · doi:10.2165/11316580-000000000-00000 · Cited by 202
Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews
Gartlehner, G., Wagner, G., Matyas, N., Titscher, V., Greimel, J., Lux, L., Gaynes, B. N., Viswanathan, M., Patel, S., & Lohr, K. N. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014912 · Cited by 192
Self-citation
Antidepressant active ingredients from herbs and nutraceuticals used in TCM: pharmacological mechanisms and prospects for drug discovery
Wang, Y.-S., Shen, C., & Jiang, J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104520 · Cited by 189
Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis
Amick, H. R., Gartlehner, G., Gaynes, B. N., Forneris, C., Asher, G. N., Morgan, L. C., Coker-Schwimmer, E., Boland, E., Lux, L. J., Gaylord, S., et al. (2015) · BMJ · doi:10.1136/bmj.h6019 · Cited by 181
Self-citation
Non-hormonal interventions for hot flushes in women with a history of breast cancer
Gabriel Rada, G., Daniel Capurro, N., Tomás Pantoja, C., Corbalán, J., Moreno, G., Luz María Letelier, S., & Vera, C. M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004923.pub2 · Cited by 162
Mirtazapine: A Review of its Use in Major Depression and Other Psychiatric Disorders
Croom, K. F., Perry, C. M., & Plosker, G. L. (2009) · CNS Drugs · doi:10.2165/00023210-200923050-00006 · Cited by 158
Agomelatine in the Treatment of Major Depressive Disorder
Kennedy, S. H., & Rizvi, S. J. (2010) · CNS Drugs · doi:10.2165/11534420-000000000-00000 · Cited by 152
Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians
Qaseem, A., Owens, D. K., Etxeandia‐Ikobaltzeta, I., Tufte, J., Cross, J. T., & Wilt, T. J. (2023) · Annals of Internal Medicine · doi:10.7326/m22-2056 · Cited by 135
KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE
Bobo, W. V., Voort, J. L. V., Croarkin, P. E., Leung, J. G., Tye, S. J., & Frye, M. A. (2016) · Depression and Anxiety · doi:10.1002/da.22505 · Cited by 123
Antidepressants and the risk of hyponatremia: a Danish register-based population study
Leth-Møller, K., Hansen, A. H., Torstensson, M., Andersen, S. E., Ødum, L., Gislasson, G., Torp-Pedersen, C. T., & Holm, E. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011200 · Cited by 121
Geraniol produces antidepressant-like effects in a chronic unpredictable mild stress mice model
Deng, X., Xue, J., Li, H., Ma, Z., Fu, Q., Qu, R., & Ma, S. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.10.008 · Cited by 107
Changes in Body Weight and Psychotropic Drugs: A Systematic Synthesis of the Literature
Dent, R., Blackmore, A., Peterson, J., Habib, R., Kay, G. P., Gervais, A., Taylor, V. H., & Wells, G. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036889 · Cited by 113
Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient
Oluboka, O. J., Katzman, M. A., Habert, J., McIntosh, D., MacQueen, G. M., Milev, R. V., McIntyre, R. S., & Blier, P. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx081 · Cited by 104
Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease
Filipović, B. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i13.3552 · Cited by 99
Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants
Reid, S., & Barbui, C. (2010) · BMJ · doi:10.1136/bmj.c1468 · Cited by 93
Complementary Therapies for Mental Health Disorders
Asher, G. N., Gerkin, J., & Gaynes, B. N. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.04.004 · Cited by 93
Self-citation
Sexual side effects of serotonergic antidepressants: Mediated by inhibition of serotonin on central dopamine release?
Bijlsma, E. Y., Chan, J. S. W., Olivier, B., Veening, J. G., Millan, M. J., Waldinger, M. D., & Oosting, R. S. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.10.004 · Cited by 89
New‐generation, non‐SSRI antidepressants: Drug‐drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others
Protti, M., Mandrioli, R., Marasca, C., Cavalli, A., Serretti, A., & Mercolini, L. (2020) · Medicinal Research Reviews · doi:10.1002/med.21671 · Cited by 71
Effects of music therapy on major depressive disorder: A study of prefrontal hemodynamic functions using fNIRS
Feng, K., Shen, C., Ma, X., Chen, G., Zhang, M.-L., Xu, B., Liu, X., Sun, J., Zhang, X., Liu, P., et al. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.03.015 · Cited by 70
Current trends in drug treatment of obsessive–compulsive disorder
Decloedt, E. H., & Stein, D. J. (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3149 · Cited by 65
Management of inflammatory bowel disease with vitamin D: Beyond bone health
Narula, N., & Marshall, J. K. (2011) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.10.015 · Cited by 62
A review of the effectiveness of antidepressant medications for depressed nursing home residents
Boyce, R. D., Hanlon, J. T., Karp, J. F., Kloke, J., Saleh, A., & Handler, S. M. (2012) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.08.009 · Cited by 58
Primary Lifelong Delayed Ejaculation: Characteristics and Response to Bupropion
Abdel‐Hamid, I. A., & Saleh, E.-S. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.02131.x · Cited by 55
Premenstrual Syndrome and Subsequent Risk of Hypertension in a Prospective Study
Bertone‐Johnson, E. R., Whitcomb, B. W., Rich-Edwards, J. W., Hankinson, S. E., & Manson, J. E. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwv159 · Cited by 53
Risperidone long-acting injectable (Risperdal Consta®) for maintenance treatment in patients with bipolar disorder
Bobo, W. V., & Shelton, R. C. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.143 · Cited by 50
Performance Measurement for Health System ImprovementPreprint
Smith, P., Mossialos, E. A., Papanicolas, I., & Leatherman, S. T. (2010) · RePEc: Research Papers in Economics · Cited by 50
Ginsenoside Rg1 attenuates chronic unpredictable mild stress-induced depressive-like effect via regulating NF-κB/NLRP3 pathway in rats
Zhang, Y., Wang, X.-B., Xue, R., Gao, X., & Li, W. (2019) · Neuroreport · doi:10.1097/wnr.0000000000001302 · Cited by 49
Efficacy and Safety of Desvenlafaxine 25 and 50 Mg/Day in a Randomized, Placebo-Controlled Study of Depressed Outpatients
Iwata, N., Tourian, K. A., HWANG, E., Mele, L., & Vialet, C. (2013) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000426323.59698.64 · Cited by 48
Supported Self-Management: A Simple, Effective Way to Improve Depression Care
Bilsker, D., Goldner, E. M., & Anderson, E. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205700402 · Cited by 45
Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials
Bradley, A. J., & Lenox‐Smith, A. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113494937 · Cited by 42
Second-generation antidepressants for seasonal affective disorder
Thaler, K. J., Delivuk, M., Chapman, A. L., Gaynes, B. N., Kaminski, A., & Gartlehner, G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008591.pub2 · Cited by 41
Self-citation
A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders
Serretti, A., Olgiati, P., Bajo, E., Bigelli, M., & Ronchi, D. D. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.572998 · Cited by 41
Risk of Seizures Associated with Antidepressant Use in Patients with Depressive Disorder: Follow-up Study with a Nested Case–Control Analysis Using the Clinical Practice Research Datalink
Bloechliger, M., Ceschi, A., Rüegg, S., Kupferschmidt, H., Kraehenbuehl, S., Jick, S. S., Meier, C. R., & Bodmer, M. (2016) · Drug Safety · doi:10.1007/s40264-015-0363-z · Cited by 40
Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries
Olgiati, P., Bajo, E., Bigelli, M., Ronchi, D. D., & Serretti, A. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.08.013 · Cited by 41
Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability
Fregni, F., Brunoni, & Fráguas, R. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s5751 · Cited by 40
Metabolic Syndrome in Severe Mental Disorders
OHAERI, J. U., & Akanji, A. O. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0053 · Cited by 40
It is time to investigate integrative approaches to enhance treatment outcomes for depression?
Lopresti, A. L. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.03.008 · Cited by 40
Comparative Benefits and Harms of Complementary and Alternative Medicine Therapies for Initial Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis
Asher, G. N., Gartlehner, G., Gaynes, B. N., Amick, H. R., Forneris, C. A., Morgan, L. C., Coker‐Schwimmer, E., Boland, E., Lux, L. J., Gaylord, S. A., et al. (2017) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2016.0261 · Cited by 37
Self-citation
Expectation-induced placebo effect on acute sadness in women with major depression: An experimental investigation
Haas, J. W., Rief, W., Glombiewski, J. A., Winkler, A., & Doering, B. K. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.056 · Cited by 37
The General and Comparative Efficacy and Safety of Duloxetine in Major Depressive Disorder
Gartlehner, G., Thaler, K. J., Hansen, R. A., & Gaynes, B. N. (2009) · Drug Safety · doi:10.2165/11318930-000000000-00000 · Cited by 34
Self-citation
The effectiveness of listening to the Holy Quran to improve mental disorders and psychological well-being: Systematic review and meta-analysisPreprint
Abd-Alrazaq, A. A., Malkawi, A. A., Maabreh, A. H., Alam, T., Bewick, B. M., Akhu‐Zaheya, L., & Househ, M. S. (2020) · Research Square · doi:10.21203/rs.3.rs-44376/v1 · Cited by 36
Trends of Acupuncture Therapy on Depression From 2011 to 2020: A Bibliometric Analysis
Xiang, H.-C., Li, J., Li, B., Tan, Q., & Cai, G. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.721872 · Cited by 32
Metabolism of Macro-elements (Calcium, Magnesium, Sodium, Potassium, Chloride and Phosphorus) and Associated Disorders
Yadav, S., Yadav, J., Kumar, S., & Singh, P. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-4723-8_8 · Cited by 30
Second-generation antidepressants for preventing seasonal affective disorder in adults
Gartlehner, G., Nußbaumer-Streit, B., Gaynes, B. N., Forneris, C. A., Morgan, L. C., Kaminski-Hartenthaler, A., Greenblatt, A. M., Wipplinger, J., Lux, L. J., Sonis, J. H., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011268.pub2 · Cited by 30
Self-citation
Factor analysis of electroacupuncture and selective serotonin reuptake inhibitors for major depressive disorder: an 8-week controlled clinical trial
Yang, X., Gong, W., Ma, X., Wang, S., Wang, X., Guo, T., Guo, Z., Sun, Y., Li, J., Zhao, B., et al. (2019) · Acupuncture in Medicine · doi:10.1136/acupmed-2017-011412 · Cited by 29
A magic pill? A qualitative analysis of patients’ views on the role of antidepressant therapy in inflammatory bowel disease (IBD)
Mikocka‐Walus, A. A., Gordon, A. L., Stewart, B. J., & Andrews, J. M. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-93 · Cited by 29
Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause
Portman, D. J., Kaunitz, A. M., Kazempour, K., Mekonnen, H., Bhaskar, S., & Lippman, J. S. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000210 · Cited by 33
Fatal venlafaxine poisonings are associated with a high prevalence of drug interactions
Launiainen, T., Rasanen, I., Vuori, E., & Ojanperä, I. A. (2010) · International Journal of Legal Medicine · doi:10.1007/s00414-010-0461-5 · Cited by 29
Exercise as a treatment modality for depression: A narrative review
Al‐Qahtani, A. M., Shaikh, M. A. K., & Shaikh, I. A. (2018) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2018.05.004 · Cited by 32
Significant reduction in depressive symptoms among patients with moderately-severe to severe depressive symptoms after participation in a therapist-supported, evidence-based mobile health program delivered via a smartphone app
Forman‐Hoffman, V. L., Nelson, B. W., Ranta, K., Nazander, A., Hilgert, O., & Quevedo, J. (2021) · Internet Interventions · doi:10.1016/j.invent.2021.100408 · Cited by 27
Association between antidepressant side effects and functional impairment in patients with major depressive disorders.
Kikuchi, T., Suzuki, T., Uchida, H., Watanabe, K., & Mimura, M. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.05.007 · Cited by 24
Cool the Inflamed Brain: A Novel Anti-inflammatory Strategy for the Treatment of Major Depressive Disorder
Su, W., Hu, T., & Jiang, C. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230809112028 · Cited by 27
Wake and light therapy for moderate-to-severe depression – a randomized controlled trial
Kragh, M., Martiny, K., Videbech, P., Møller, D. N., Wihlborg, C. S., Lindhardt, T., & Larsen, E. R. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12741 · Cited by 25
A Comparative, Developmental, and Clinical Perspective of Neurobehavioral Sexual Dimorphisms
Viveros, M., Mendrek, A., Paus, T., López-Rodríguez, A. B., Marco, E. M., Yehuda, R., Cohen, H., Lehrner, A. L., & Wagner, E. J. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00084 · Cited by 26
Unleashing lactoferrin's antidepressant potential through the PI3K/Akt/mTOR pathway in chronic restraint stress rats
Ahmed, H. H., Essam, R. M., El-Yamany, M. F., Ahmed, K. A., & El-Sahar, A. E. (2023) · Food & Function · doi:10.1039/d3fo02222f · Cited by 25
Barriers to achieving treatment goals: A focus on sleep disturbance and sexual dysfunction
Morehouse, R. L., MacQUEEN, G. M., & Kennedy, S. H. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.047 · Cited by 25
Risk of Dementia Among Elderly Nursing Home Patients Using Paroxetine and Other Selective Serotonin Reuptake Inhibitors
Bali, V., Chatterjee, S., Carnahan, R. M., Chen, H., Johnson, M. L., & Aparasu, R. R. (2015) · Psychiatric Services · doi:10.1176/appi.ps.201500011 · Cited by 23
Differences in Efficacy and Safety of Pharmaceutical Treatments between Men and Women: An Umbrella Review
Gartlehner, G., Chapman, A. L., Strobelberger, M., & Thaler, K. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011895 · Cited by 22
Self-citation
Impact of Drug Tolerability on the Selection of Antidepressant Treatment in Patients With Major Depressive Disorder
Ginsberg, L. D. (2009) · CNS Spectrums · doi:10.1017/s1092852900026353 · Cited by 19
Deceptive and non-deceptive placebos to reduce sadness: A five-armed experimental study
Friehs, T., Rief, W., Glombiewski, J., Haas, J., & Kube, T. (2022) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2022.100349 · Cited by 17
Comparable efficacy and safety of 8 weeks treatment with agomelatine 25–50 mg or fluoxetine 20–40 mg in Asian out-patients with major depressive disorder
Shu, L., Sulaiman, A. H., Huang, Y., Leng, C. F. S., Crutel, V., & Kim, Y. S. (2013) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2013.09.009 · Cited by 19
Seizures during antidepressant treatment in psychiatric inpatients—results from the transnational pharmacovigilance project “Arzneimittelsicherheit in der Psychiatrie” (AMSP) 1993–2008
Köster, M., Grohmann, R., Engel, R. R., Nitsche, M. A., Rüther, E., & Degner, D. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3281-8 · Cited by 18
Liking of salt is associated with depression, anxiety, and stress
Ferraris, C., Scarlett, C. J., Bucher, T., & Beckett, E. (2023) · Chemical Senses · doi:10.1093/chemse/bjad038 · Cited by 18
Symptom management in inflammatory bowel disease
Abraham, B. P. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1038241 · Cited by 17
Clinical management of major depressive disorder with comorbid obesity
Opel, N., Hanßen, R., Steinmann, L. A., Roempler, J., Köhler‐Forsberg, O., Hahn, M., Ferretti, F., Palmer, C., Penninx, B. W. J. H., Gold, S. M., et al. (2025) · The Lancet Psychiatry · doi:10.1016/s2215-0366(25)00193-2 · Cited by 20
Syndrome métabolique chez les patients atteints de schizophrénie indépendamment de la prise d’antipsychotiques atypiques
Khalil, R. B. (2011) · La Presse Médicale · doi:10.1016/j.lpm.2011.10.013 · Cited by 19
Premature Ejaculation: Bother and Intravaginal Ejaculatory Latency Time in Iran
Zargooshi, J. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01468.x · Cited by 16
Newer antidepressants for the treatment of depression in adults
Hatcher, S., & Arroll, B. (2012) · BMJ · doi:10.1136/bmj.d8300 · Cited by 15
Management of side effects of antidepressants - brief review of recommendations from guidelines for treatment of major depressive disorder.
Uzun, S., & Kozumplik, O. (2009) · PubMed · Cited by 15
Tolerability of High-Dose Venlafaxine After Switch From Escitalopram in Nonresponding Patients With Major Depressive Disorder
Engelmann, J., Wagner, S., Solheid, A., Herzog, D. P., Dreimüller, N., Müller, M. B., Tadić, A., Hiemke, C., & Lieb, K. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001312 · Cited by 14
A Pill for the Ill? Depression, Medicalization and Public Health.
Vilhelmsson, A. (2014) · Socialmedicinsk tidskrift · doi:10.62607/smt.v91i1.43076 · Cited by 14
Alcohol use disorder in the COVID‐19 era: Position paper of the Italian Society on Alcohol (SIA)
Testino, G., Vignoli, T., Patussi, V., Allosio, P., Amendola, M. F., Aricò, S., Baselice, A., Balbinot, P., Campanile, V., Fanucchi, T., et al. (2021) · Addiction Biology · doi:10.1111/adb.13090 · Cited by 13
Second-generation antidepressants for preventing seasonal affective disorder in adults
Gartlehner, G., Nußbaumer-Streit, B., Gaynes, B. N., Forneris, C. A., Morgan, L. C., Greenblatt, A. M., Wipplinger, J., Lux, L. J., Noord, M. V., & Winkler, D. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011268.pub3 · Cited by 14
Self-citation
Risk of adverse events in treatment-resistant depression: propensity-score-matched comparison of antidepressant augment and switch strategies
Hansen, R. A., Dusetzina, S. B., Ellis, A. R., Stürmer‎, T., Farley, J. F., & Gaynes, B. N. (2011) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2011.10.001 · Cited by 13
Self-citation
Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy
Nicola, M. D., Dell’Osso, B. M., Peduto, I., Cipelli, R., Pugliese, A. C., Signorelli, M. S., Ventriglio, A., & Martinotti, G. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220411092813 · Cited by 16
Risk of Cognitive Decline Associated With Paroxetine Use in Elderly Nursing Home Patients With Depression
Bali, V., Chatterjee, S., Johnson, M. L., Chen, H., Carnahan, R. M., & Aparasu, R. R. (2016) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317516673463 · Cited by 12
Surveillance of Antidepressant Safety (SADS): Active Signal Detection of Serious Medical Events Following SSRI and SNRI Initiation Using Big Healthcare Data
Aakjær, M., Bruin, M. L. D., Külahçı, M., & Andersen, M. T. (2021) · Drug Safety · doi:10.1007/s40264-021-01110-x · Cited by 13
Prevalence and associated factors with traditional, complementary and integrative medicine in Brazil: A population-based study
Faisal‐Cury, A., & Rodrigues, D. M. D. O. (2022) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2022.102146 · Cited by 11
Characterisation of medication side effects in patients with mostly resistant depression in a real-world setting
Panariello, F., Kasper, S., Zohar, J., Souery, D., Montgomery, S., Ferentinos, P., Rujescu, D., Mendlewicz, J., Ronchi, D. D., Serretti, A., et al. (2022) · World Journal of Biological Psychiatry · doi:10.1080/15622975.2022.2134588 · Cited by 13
Adverse event profiles of drug-induced liver injury caused by antidepressant drugs: a disproportionality analysis
Jiang, A., Wei, C., Zhu, W., Wu, F., & Wu, B. (2024) · Therapeutic Advances in Drug Safety · doi:10.1177/20420986241244585 · Cited by 12
Comparative Effectiveness of Second‐Generation Antidepressants in Reducing the Risk of Dementia in Elderly Nursing Home Residents with Depression
Bali, V., Holmes, H. M., Johnson, M. L., Chen, H., Fleming, M. L., & Aparasu, R. R. (2016) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1680 · Cited by 11
Safety and Tolerability of Dexmecamylamine (TC-5214) Adjunct to Ongoing Antidepressant Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy
Tummala, R., Desai, D., Szamosi, J., Wilson, E., Hosford, D. A., Dunbar, G. C., & Eriksson, H. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000269 · Cited by 11
Combining Structure‐Based Pharmacophore andIn SilicoApproaches to Discover Novel Selective Serotonin Reuptake Inhibitors
Zhou, Z.-L., Liu, H., Wu, J. W., Tsao, C., Chen, W., Liu, K., & Ho, Y. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12192 · Cited by 10
Potential effects of rational prescribing on national health care spending: More than half a billion dollars in annual savings.
Littman, J., & Halil, R. (2016) · PubMed Central · Cited by 10
A Scoping Review of Correctional-Based Interventions for Women Prisoners with Mental Health Problems
Hidayati, N. O., Suryani, S., Rahayuwati, L., Fitrasanti, B. I., & Ahmad, C. A. (2023) · Social Sciences · doi:10.3390/socsci12080452 · Cited by 10
Efficacy of Desvenlafaxine Compared With Placebo in Major Depressive Disorder Patients by Age Group and Severity of Depression at Baseline
Mosca, D., Zhang, M., Prieto, R., & Boucher, M. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000674 · Cited by 9
Prescribing safety: the case of inappropriate medicines
Payne, R. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x593730 · Cited by 9
OUTdoor Swimming as a nature-based Intervention for DEpression (OUTSIDE): study protocol for a feasibility randomised control trial comparing an outdoor swimming intervention to usual care for adults experiencing mild to moderate symptoms of depression
Massey, H. C., Denton, H., Burlingham, A., Violato, M., Bibby-Jones, A.-M., Cunningham, R., Ciccognani, S., Robertson, S., & Strauss, C. (2023) · Pilot and Feasibility Studies · doi:10.1186/s40814-023-01358-3 · Cited by 10
Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA)
Testino, G., Vignoli, T., Patussi, V., Allosio, P., Amendola, M. F., Aricò, S., Baselice, A., Balbinot, P., Campanile, V., Fanucchi, T., et al. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07006-1 · Cited by 8
Epilepsy in Psychiatric Disorders
Beghi, M., Beghi, E., & Cornaggia, C. (2015) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-22159-5_16 · Cited by 8
An Approach to Symptoms at the Interface of Medicine and Psychiatry: Pain, Insomnia, Weight Loss and Anorexia, Fatigue and Forgetfulness, and Sexual Dysfunction
Freudenreich, O., Kontos, N. J., Nejad, S. H., & Gross, A. F. (2010) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.08.006 · Cited by 7
Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial
Mönnikes, H., Schwan, T., Rensburg, C. V., Straszak, A., Theek, C., Lühmann, R., Sander, P., & Tholen, A. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-145 · Cited by 7

Authors: Gartlehner, G., Thieda, P., Hansen, R. A., Gaynes, B. N., DeVeaugh-Geiss, A., Krebs, E. E., & Lohr, K. N.
Affiliations: Universität für Weiterbildung Krems (AT)
University of North Carolina at Chapel Hill (US)
Regenstrief Institute (US)
RTI International (US)
Corresponding author: Gartlehner, Gerald
ORCID: Gartlehner, Gerald
Hansen, Richard A
Gaynes, Bradley N
Krebs, Erin E
Lohr, Kathleen N
Venue: Drug Safety
Publisher: Springer Science and Business Media LLC
Published: 2008
Volume: 31
Issue: 10
Pages: 851-865
ISSN: 0114-5916 (ISSN-L)
DOI: 10.2165/00002018-200831100-00004
OpenAlex: W2006078781
Cited by: 150
References: 141
Citations by year: 2026: 5 · 2025: 8 · 2024: 4 · 2023: 8 · 2022: 7 · 2021: 8 · 2020: 4 · 2019: 7 · 2018: 3 · 2017: 6 · 2016: 9 · 2015: 10 · 2014: 7 · 2013: 11 · 2012: 10
FWCI: 9.85
Type: journal article
Language: en
Open access: closed
Locations: Drug Safety (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Public Health Service (290-02-0016)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords: second-generation antidepressants, major depressive disorder, adverse drug reactions, drug safety comparison, venlafaxine, selective serotonin reuptake inhibitors, paroxetine, bupropion, mirtazapine, sertraline, sexual adverse effects, weight gain, nausea and vomiting, diarrhea, discontinuation rate, net benefit
MeSH terms: Adult, Blood Pressure, Depressive Disorder, Major, Major Depressive Disorder, Humans, Nausea, Seizures, Sexual Dysfunction, Physiological, Vomiting, Treatment Outcome, Risk Assessment, Antidepressive Agents, Second-Generation, Sexual Dysfunctions, Psychological

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Comparative Risk for Harms of Second-Generation Antidepressants: A Systematic Review and Meta-Analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks